Fig 1.
Survey design.
Fig 2.
Frequency distribution of excluded patients.
Table 1.
Comparison of clinical characteristics between VA-AKI and No-AKI patients.
Table 2.
Comparison of concomitant drugs used between VA-AKI and No-AKI patients.
Table 3.
TDM of patients treated with VAN.
Table 4.
Risk factors for VA-AKI.
Table 5.
VA-AKI treatments characteristics.
Table 6.
VA-AKI patients’ renal function at the time of death.
Table 7.
Risk factors for death in VA-AKI patients.
Table 8.
Risk factors for renal outcome in VA-AKI patients.
Table 9.
Akaike score and a table of the classification of the model.